“There were serious long-term and chronic health consequences for...
Category:
Health
Latest
Smoke from Canada wildfires deteriorates New York air quality; surpasses New Delhi’s pollution level
Situation was such that the picturesque and renowned skyline of New...
AI outperforms standard risk model for predicting breast cancer: Study
''Recent advances in AI deep learning provide us with the ability...
Private sector should be an ally In India’s big vaccine push
The ugly truth about India is that its problems rarely revolve around production; too often they center on distribution. We produce more than enough food but can’t distribute it to our population, so we have a third of the world’s malnourished children. While we generate more than enough electricity, our distribution system is inefficient and unprofitable – and so businesses and homes are plagued by constant power cuts.
Coronavirus vaccine to cost $3-4 to govt; $6-8 in private market: SII
“We want the vaccine to be affordable and accessible to all. The government of India will receive it at a far more affordable price of USD 3-4, since they will be buying in a larger volume,” said Adar Poonawalla,CEO,Serum Institute of India,
Sufficient Covid-19 Vaccines For First Phase Of Vaccination Drive: V K Paul
“Our first phase (of vaccination) comprises priority groups with a high risk of mortality and our healthcare and frontline workers. For them, we believe, we have enough (Covid-19 vaccine) stockpile,” V K Paul,Chairman of National Expert Group On Vaccine Administration for Covid-19, told PTI in an interview.
Wildlife, land-use change and health infra: Scientists identify ways of preventing next pandemic
Following several multidisciplinary studies in 2020, scientists now firmly believe a “perfect storm” for an outbreak with pandemic potential is created by the combined forces of land-use change, high population density and the presence of interfaces between wildlife and domestic animals.
Germany mulls delaying second COVID-19 vaccine shot, Denmark approves delay
Some German health experts have welcomed Britain’s move to delay administering a second dose of the BioNTech/Pfizer shot, which comes as governments try to provide protection against coronavirus to as many people as possible by giving them one shot and delaying a second.
However, BioNTech and Pfizer pointed in a joint statement to a lack of trial data to support delaying the second dose.
Global Covid-19 cases surpass 85 million mark: Johns Hopkins University
The US is the worst-hit country with the world’s highest number of cases and deaths at 20,626,686 and 351,453, respectively, according to the CSSE.
India comes in second place in terms of cases at 10,323,965, while the country’s death toll soared to 149,435.
Brazil currently accounts for the second highest number of fatalities at 196,018.
1 Jan renewals:Reinsurers arrest downward pricing, say no to ongoing Contagious Disease exposures
Improving investment markets, retained earnings and newly raised capital helped global reinsurance capital levels to recover rapidly during 2020, ending the year 3% higher than at year-end 2019.
For buyers, terms and conditions have overall been less onerous than initially feared again revealing the efficient working of the global reinsurance market,
Emerging COVID-19 losses, often advised only late in the renewal process or yet to be advised, triggered technical discussions of primary policy coverage and reinsurance treaty wordings.
Both remain in the early stages of deliberation, so, sensibly, most programmes renewed without considering any potential COVID-19 losses, leaving time for more measured discussions and subsequent adjustments.
As end to pandemic mask-wearing nears, South Koreans scramble to arrange cosmetic surgery in the future
“Both surgical and non-surgical inquiries about eyes, eyebrows, nose bridge and foreheads – the only visible parts – certainly increased,” said Park Cheol-woo, a surgeon at WooAhIn Plastic Surgery Clinic, who was in charge of Ryu’s operation.
India bars virus vaccine maker from exporting
The company also has been barred from selling the vaccine on the private market.
As a result, Adar Poonawalla, Serum Institute’s CEO said, the export of vaccines for COVAX — the ambitious initiative created to ensure equitable access to COVID-19 vaccines set up by the World Health Organization, vaccines alliance GAVI and CEPI, a global coalition to fight epidemics — won’t begin until March or April.
Bharat Biotech says approved COVID shot trials ‘honest’
Health Minister Harsh Vardhan clarified on Twitter on Sunday that the emergency use approval for COVAXIN was “in clinical trial mode”, wherein all recipients of the vaccine would be tracked and monitored as if they were in trial.